Therapeutic intervention strategies for Nipah virus infection: a scoping review

医学 干预(咨询) 病毒学 梅德林 重症监护医学 免疫学 病毒 2019年冠状病毒病(COVID-19) 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 大流行 2019-20冠状病毒爆发 流行病学 传输(电信) 疾病 接种疫苗
作者
Ikhwan Yuda Kusuma,Bizhar Ahmed Tayeb,Muhammad Jayyid Zidan,Septi Nurkhasanah,Rian Nurahman,Ilil Maidatuz Zulfa
出处
期刊:Scandinavian Journal of Infectious Diseases [Informa]
卷期号:58 (6): 571-584 被引量:1
标识
DOI:10.1080/23744235.2026.2649531
摘要

Introduction Nipah virus (NiV) infection, a zoonotic disease, has caused recurrent outbreaks in South and Southeast Asia, with case fatality rates ranging from 38% to 75%. The clinical management of NiV disease (NiVD) relies on supportive care, with unapproved antiviral therapies and no licensed vaccines currently available.Objectives This scoping review aims to synthesise and map the available evidence on therapeutic strategies for NiV infection.Methods A systematic search was conducted in PubMed and Scopus for studies published from 1 January 1999 to 1 February 2026, focusing on clinical studies, animal experiments, in vitro investigations and in silico analyses evaluating NiV therapies. Eligible studies were selected based on their population or experimental model, therapeutic intervention, evaluation methods, efficacy outcomes, safety findings and proposed molecular mechanisms.Results Of 1703 articles screened, 16 studies were included, covering clinical reports, animal models, in vitro experiments and in silico analyses. Therapeutic interventions evaluated included antivirals (ribavirin, favipiravir, remdesivir and RdRp-targeted candidates), passive immunotherapy (monoclonal antibodies targeting viral glycoproteins) and computationally prioritised compounds (e.g. phytochemicals, bioisosteres and repurposed drugs). Most interventions targeted viral entry, RNA replication or multiple stages of the NiV life cycle. However, a substantial gap exists between the urgent clinical need for effective treatments and the limited availability of clinically validated therapies.Conclusion Effective, clinically validated therapies for NiV infection are still lacking. Translational research, outbreak-ready clinical trial frameworks and prioritisation of promising therapeutic candidates are crucial for improving preparedness and clinical outcomes in future NiV outbreaks.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后的应助被科研通管家采纳,获得10
刚刚
秋风的应助被科研通管家采纳,获得10
刚刚
刚刚
DrMA的应助被科研通管家采纳,获得50
刚刚
华仔的应助被科研通管家采纳,获得10
1秒前
隐形曼青的应助被科研通管家采纳,获得10
1秒前
苹果姐完成签到 ,获得积分10
1秒前
爆米花的应助被科研通管家采纳,获得10
1秒前
初景的应助被糖糖采纳,获得20
1秒前
1秒前
极限001的应助被科研通管家采纳,获得50
1秒前
赘婿的应助被科研通管家采纳,获得10
1秒前
JamesPei的应助被科研通管家采纳,获得10
1秒前
kuba发布了新的文献求助10
2秒前
licuhnol完成签到,获得积分20
2秒前
3秒前
柔弱烧鹅完成签到,获得积分10
4秒前
斯文败类的应助被夏诗婷采纳,获得10
4秒前
否决权完成签到,获得积分10
4秒前
DW的应助被顺心的星月采纳,获得10
4秒前
大白兔完成签到 ,获得积分10
4秒前
秋秋发布了新的文献求助10
5秒前
爱火未灭完成签到,获得积分10
5秒前
所所的应助被哈哈采纳,获得10
5秒前
Emily完成签到,获得积分20
6秒前
YaoHui完成签到,获得积分10
8秒前
8秒前
莱特昊完成签到,获得积分10
8秒前
8秒前
这么近那么远完成签到,获得积分20
9秒前
丁丁当当发布了新的文献求助10
9秒前
Yurmas完成签到,获得积分10
10秒前
啦你完成签到 ,获得积分10
11秒前
11秒前
12秒前
molihuakai的应助被yz123采纳,获得10
12秒前
吉吉国王完成签到 ,获得积分10
12秒前
YaoHui发布了新的文献求助10
13秒前
大模型的应助被小燕尾条采纳,获得10
14秒前
zhu发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175142
求助须知:如何正确求助?哪些是违规求助? 9566928
关于积分的说明 21789123
捐赠科研通 7769522
什么是DOI,文献DOI怎么找? 3431822
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477222